PICO Portalanswers from OpenAlex
National Vaccine and Serum Institute
InstitutionResearch output, impact & collaborations
National Vaccine and Serum Institute is a institution indexed in PICO Portal from OpenAlex.
What is known about National Vaccine and Serum Institute?
PICO Portalrecord summary
National Vaccine and Serum Institute is a research organisation in Beijing, CN. OpenAlex records 1,167 works and 80,716 citations for it. 477 researchers list it as their most recent affiliation.
How many works does National Vaccine and Serum Institute have?
PICO Portalindexed works
National Vaccine and Serum Institute has 1,167 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does National Vaccine and Serum Institute have?
PICO Portalcitation count
National Vaccine and Serum Institute has 80,716 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at National Vaccine and Serum Institute?
PICO Portalresearcher count
National Vaccine and Serum Institute has 477 researchers in the PICO Portal index.
What is the average h-index at National Vaccine and Serum Institute?
PICO Portalavg h-index
National Vaccine and Serum Institute has an average h-index of 66 in OpenAlex.
What is the ROR of National Vaccine and Serum Institute?
PICO Portalror
The ROR for National Vaccine and Serum Institute is on the source record.
What is the OpenAlex record for National Vaccine and Serum Institute?
PICO Portalopenalex
The OpenAlex for National Vaccine and Serum Institute is on the source record.
Who are the most-cited researchers behind National Vaccine and Serum Institute?
PICO Portaltop researchers by citations
What are the most-cited papers on National Vaccine and Serum Institute?
PICO Portalmost cited works
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Kai Wang, Sean R. Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M. Sanford, Peter An, James Sun, Frank Juhn, Kristina Brennan, Kiel Iwanik, Ashley Maillet, Jamie Buell, Emily White, Mandy Zhao, Sohail Balasubramanian, Selmira Terzic, Tina Richards, Vera Banning, Lázaro Ibrahim Romero García, Kristen Mahoney, Zac Zwirko, Amy Donahue, Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin, Snjezana Doğan, Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher, Kevin Lin, Amit M. Oza, Clare L. Scott, Heidi Giordano, James Sun, Gottfried E. Konecny, Robert L. Coleman, Anna V. Tinker, David M. O’Malley, Rebecca Kristeleit, Ling Ma, Katherine M. Bell‐McGuinn, James D. Brenton, Janiel M. Cragun, Ana Oaknin, Isabelle Ray‐Coquard, Maria I. Harrell, Elaina Mann, Scott H. Kaufmann, Anne Floquet, Alexandra Léary, Thomas C. Harding, Sandra Goble, Lara Maloney, Jeff Isaacson, Andrew R. Allen, Lindsey Rolfe, Roman Yelensky, Mitch Raponi, Iain A. McNeish
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A. Curran, Sohail Balasubramanian, Troy Bloom, Kristina Brennan, Amy Donahue, Sean R. Downing, Garrett M. Frampton, Lázaro Ibrahim Romero García, Frank Juhn, Kathy C Mitchell, Emily White, Jared White, Zac Zwirko, Tamar Peretz, Hovav Nechushtan, Lior Soussan‐Gutman, Jhingook Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-Il Park, Dalia Ercan, Christine E. Sheehan, Jeffrey S. Ross, Maureen Cronin, Pasi A. Jänne, Philip J. Stephens
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Juliann Chmielecki, Xinyuan Lu, Todd M. Bauer, Mikhail Akimov, José A. Bufill, Carrie B. Lee, David Jentz, Rick Hoover, Sai‐Hong Ignatius Ou, Ravi Salgia, Timothy J. Brennan, Zachary R. Chalmers, Savina Jaeger, Alan Huang, Julia A. Elvin, Rachel Erlich, Alex Fichtenholtz, Kyle Gowen, Joel Greenbowe, Adrienne Johnson, Depinder Khaira, Caitlin McMahon, Eric M. Sanford, Steven Roels, Jared White, Joel Greshock, Robert Schlegel, Doron Lipson, Roman Yelensky, Deborah Morosini, Jeffrey S. Ross, Eric A. Collisson, Malte Peters, Philip J. Stephens, Vincent A. Miller
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
Christine H. Chung, Violeta Beleva Guthrie, David L. Masica, Collin Tokheim, Hyunseok Kang, Jeremy D. Richmon, Nishant Agrawal, Carole Fakhry, Harry Quon, Rathan M. Subramaniam, Zhixiang Zuo, T. Seiwert, Zachary R. Chalmers, Garrett M. Frampton, Siraj M. Ali, Roman Yelensky, Philip J. Stephens, V.A. Miller, Rachel Karchin, Justin A. Bishop
How much of the research on National Vaccine and Serum Institute is open access?
PICO Portalopen access share
80%OPEN ACCESS